SCHEMBL2552675

SCHEMBL2552675

O=C(O)/C=C/C=C/CCCCCCCCCCCCC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FASN P49327 1/20 0.67
▸ KDM4E B2RXH2 1/20 0.65
▸ MAPT P10636 3/20 0.55
▸ ABCC4 O15439 1/20 0.55
▸ PPARG P37231 6/20 0.55
▸ PPARA Q07869 5/20 0.55
▸ TERT O14746 3/20 0.55
▸ PTPN1 P18031 3/20 0.55
▸ PPARD Q03181 3/20 0.55
▸ BLM P54132 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ FABP4 P15090 2/20 0.55
▸ F7 P08709 2/20 0.55
▸ F3 P13726 2/20 0.55
▸ GMNN O75496 1/20 0.55
▸ USP2 O75604 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2554152 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL2552676 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL2913090 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL7854528 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL14673141 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL2554147 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL2554348 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL2555437 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL2555134 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG
SCHEMBL7854525 1.00 FASN (0.67) FASNKDM4EMAPTABCC4PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011124228-A1 A BIOCIDAL POLYOLEFIN YARN WITH 3-12 FILAMENTS VESTERGAARD FRANDSEN SA (CH) 2011-10-13 — — WO claimed
WO-2011124227-A1 BIOCIDAL ACID-ADJUSTED POLYMER WITH POLYPROPYLENE VESTERGAARD FRANDSEN SA (CH) 2011-10-13 — — WO claimed
CN-107261148-B Methylphenidate prodrugs, methods of making and using the same 凯姆制药公司 2021-07-13 — — CN disclosed
US-20130267547-A1 PRODRUGS UTILIZING A TRANSPORTER-DIRECTED UPTAKE MECHANISM VIRGINIA COMMONWEALTH UNIVERSITY 2013-10-10 — — US disclosed
EP-2624869-A2 PRODRUGS UTILIZING A TRANSPORTER DIRECTED UPTAKE MECHANISM Virginia Commonwealth University (US) 2013-08-14 — — EP disclosed
WO-2012048204-A2 PRODRUGS UTILIZING A TRANSPORTER DIRECTED UPTAKE MECHANISM VIRGINIA COMMONWEALTH UNIVERSITY (US) 2012-04-12 — — WO disclosed
WO-2011124227-A1 BIOCIDAL ACID-ADJUSTED POLYMER WITH POLYPROPYLENE VESTERGAARD FRANDSEN SA (CH) 2011-10-13 — — WO disclosed
WO-2011124228-A1 A BIOCIDAL POLYOLEFIN YARN WITH 3-12 FILAMENTS VESTERGAARD FRANDSEN SA (CH) 2011-10-13 — — WO disclosed
US-20070041931-A1 Compositions Comprising Soy Products and Dioic Acids JOHNSON & JOHNSON CONSUMER FRANCE, SAS (FR) 2007-02-22 — — US disclosed
EP-1677748-A1 COMPOSITIONS COMPRISING SOY PRODUCTS AND DIOIC ACIDS Johnson & Johnson Consumer France SAS (FR) 2006-07-12 — — EP disclosed
WO-2005048969-A1 COMPOSITIONS COMPRISING SOY PRODUCTS AND DIOIC ACIDS JOHNSON & JOHNSON CONSUMER FRANCE S.A.S. (FR) 2005-06-02 — — WO disclosed
US-6777213-B2 USING A SOLVENT CONTAINING AT LEAST ONE OLEFIN WITHOUT THE NEED FOR FIRST REMOVING THE SPENT MICROORGANISM CELLS COGNIS CORPORATION 2004-08-17 — — US disclosed
US-6692971-B2 QUALITATIVE AND QUANTITATIVE ANALYSIS IN BIOLOGICAL SAMPLES BY ESTERIFYING ACID AND USING TANDEM MASS SPECTROSCOPY USING ATMOSPHERIC PRESSURE IONIZATION TECHNIQUES IN THE POSITIVE MODE; DIAGNOSIS OF VITAMIN B12 DEFICIENCY UNIVERSITY OF UTAH RESEARCH FOUNDATION 2004-02-17 — — US disclosed
US-20020019056-A1 Method of analyzing dicarboxylic acids UNIVERSITY OF UTAH RESEARCH FOUNDATION 2002-02-14 — — US disclosed
US-4383090-A HIGH SPEED; COCURING AGENT OF POLYAMIDE-POLYLACTAM COPOLYMER; FILMS; CASTINGS; POTTING; ADHESIVES DIAMOND SHAMROCK CORPORATION (US) 1983-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267547-A1 PRODRUGS UTILIZING A TRANSPORTER-DIRECTED UPTAKE MECHANISM SLC27A1, SLC27A2, SLC2A1 FASN 91/4885KDM4E 3365/4885MAPT 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback